AKT1 and B-cell chronic lymphocytic leukemia: Thereby, AKT and BCR signaling, NF-κB activation, modulation of apoptosis and the expression of CD20 (see below) constitute the main targets of miRNAs, by which CLL cells achieve drug resistance (Figure 3).